Praxis Precision Medicines PRAX
NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) EBIT (2019 - 2026)

Praxis Precision Medicines (PRAX) posted EBIT of -$96.9 million for Q2 2026, up 8.46% on a QoQ basis from -$105.9 million in Q1 2026, and down 27.39% year-over-year from -$133.5 million in Q2 2025.

Analysis

Praxis Precision Medicines (PRAX) EBIT (2019 - 2026) Analysis & Trends

Praxis Precision Medicines has reported EBIT for 8 years, with the latest figure at -$96.9 million in Q2 2026.

  • On a quarterly basis, EBIT fell 27.39% year-over-year to -$96.9 million in Q2 2026; TTM through Jun 2026 was -$378.2 million, a 39.24% decrease from a year earlier, with the FY2025 full-year figure at -$326.2 million, down 62.96% from the prior year.
  • EBIT was -$96.9 million for Q2 2026 at Praxis Precision Medicines, up from -$105.9 million in the prior quarter.
  • The five-year high for EBIT was -$25.5 million in Q3 2023, with the low at -$105.9 million in Q1 2026.
  • Average EBIT over 5 years is -$59.5 million, with a median of -$58.6 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2023: EBIT plunged 151.1% in 2022, then jumped 44.67% in 2023.
  • Over 5 years, EBIT stood at -$41.5 million in 2022, then jumped by 32.92% to -$27.8 million in 2023, then slumped by 130.01% to -$64.0 million in 2024, then tumbled by 51.74% to -$97.0 million in 2025, then rose by 0.14% to -$96.9 million in 2026.
  • The last three EBIT figures came in at -$96.9 million (Q2 2026), -$105.9 million (Q1 2026), and -$97.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 1.29 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn -815.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn 493.00 Mn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn 231.44 Mn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn -365.99 Mn
10 Praxis Precision Medicines 8.34 Bn 7.58 Bn - -96.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -96.90 Mn
Mar 31, 2026 -105.86 Mn
Dec 31, 2025 -97.04 Mn
Sep 30, 2025 -78.36 Mn
Jun 30, 2025 -76.07 Mn
Mar 31, 2025 -74.73 Mn
Dec 31, 2024 -63.96 Mn
Sep 30, 2024 -56.84 Mn
Jun 30, 2024 -37.49 Mn
Mar 31, 2024 -41.89 Mn
Dec 31, 2023 -27.81 Mn
Sep 30, 2023 -25.52 Mn
Jun 30, 2023 -34.96 Mn
Mar 31, 2023 -38.09 Mn
Dec 31, 2022 -41.45 Mn
Sep 30, 2022 -44.29 Mn
Jun 30, 2022 -60.39 Mn
Mar 31, 2022 -68.85 Mn
Dec 31, 2021 -58.66 Mn
Sep 30, 2021 -44.77 Mn
API Access

Praxis Precision Medicines EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=PRAX&period=max&api_key=YOUR_API_KEY